ACI Clinical
About ACI Clinical
ACI Clinical has been offering timely, objective, actionable medical/safety/data guidance and decision support tools to reduce risk and guarantee patient safety in clinical trials since our founding in 2001.
More in Clinical Research
ABX-CRO
the independent, full-service CRO for cutting-edge studies in molecular imaging, cancer, and neuroscience. We are happy to develop your product from bench to bedside using a distinctive translational medicine strategy.
International Animal Health Journal
Looking into the entire outsourcing management of the Veterinary Drugs, Veterinary Devices & Animal Feed Industry. The International Animal Health Journal (IAHJ) is the journal that the animal health industry has been missing: a comprehensive guidebook, packed with both practical and scholarly information. Medical, veterinary, technical, and professional knowledge, is accurate, precise, and objective, crucial to keeping animals healthy and animal-derived food safe. This journal is dedicated to pharmaceutical professionals, medical device manufacturers, animal feed producers, and public health officials.
Novavax, Inc.
A late-stage biotechnology business called Novavax, Inc. (Nasdaq: NVAX) works to advance global health by discovering, creating, and commercializing novel vaccines to fend off deadly infectious illnesses. Clinical studies are being conducted for NVX-CoV2373, a vaccine candidate by Novavax against COVID-19's causative virus, SARS-CoV-2. In the Phase 1 section of the Phase 1/2 clinical study, NVXCoV2373 was usually well tolerated and produced significant antibody responses that were quantitatively greater than those found in human convalescent sera. In its critical Phase 3 clinical study in older individuals, NanoFluTM, its quadrivalent influenza nanoparticle vaccine, achieved all major goals. Both vaccination candidates use Novavax's patented Matrix-MTM adjuvant, which is based on saponins and stimulates the production of large quantities of neutralizing antibodies. A renowned producer of recombinant vaccines, Novavax's
